ASML three-lens brief
Evidence-based stock research on ASML. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Underperforming SPY by 14.9pp over 30 days. · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Underperforming SPY by 14.9pp over 30 days.
- Analyst mean target $2124.23 — 38% above current (17 analysts).
ASML closed at $1534.42 (+1.76%) as of 2026-11-12. Market cap: $591.39B. P/E (trailing) 37.8. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $2124.23 — 38% above current (17 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; underperforming SPY by 14.9pp over 30 days.. Last quarter: Revenue $11.66B, net income $4.96B, free cash flow $10.37B.
Why three lenses on ASML, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ASML across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ASML" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ASML brief"></iframe>